These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6540128

  • 1. A new concept for the effector mechanism of intravenous immunoglobulin in hemocytopenias.
    Mueller-Eckhardt C, Salama A, Kiefel V, Küenzlen E, Förster C.
    Blut; 1984 Jun; 48(6):353-6. PubMed ID: 6540128
    [No Abstract] [Full Text] [Related]

  • 2. High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura.
    Carroll RR, Noyes WD, Kitchens CS.
    JAMA; 1983 Apr 01; 249(13):1748-50. PubMed ID: 6402619
    [Abstract] [Full Text] [Related]

  • 3. Fixation of C3 to platelets in vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura.
    McMillan R, Martin M.
    Br J Haematol; 1981 Feb 01; 47(2):251-6. PubMed ID: 7193475
    [Abstract] [Full Text] [Related]

  • 4. Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity.
    Berger M, Rosenkranz P, Brown CY.
    Clin Immunol Immunopathol; 1985 Feb 01; 34(2):227-36. PubMed ID: 4038476
    [Abstract] [Full Text] [Related]

  • 5. Effect of intravenous immunoglobulin in immune thrombocytopenia.
    Salama A, Mueller-Eckhardt C, Kiefel V.
    Lancet; 1983 Jul 23; 2(8343):193-5. PubMed ID: 6135031
    [Abstract] [Full Text] [Related]

  • 6. High dose intravenous IgG reduces platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura.
    Winiarski J, Kreuger A, Ejderhamn J, Holm G.
    Scand J Haematol; 1983 Oct 23; 31(4):342-8. PubMed ID: 6312557
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Organ-specific autoimmune diseases. 7) Autoimmune hematologic diseases].
    Ozaki S.
    Nihon Rinsho; 1988 Apr 23; 46(4):931-5. PubMed ID: 3404715
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease.
    Lehman HA, Lehman LO, Rustagi PK, Rustgi RN, Plunkett RW, Farolino DL, Conway J, Logue GL.
    N Engl J Med; 1987 Jan 22; 316(4):194-8. PubMed ID: 3796693
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.
    Fehr J, Hofmann V, Kappeler U.
    N Engl J Med; 1982 May 27; 306(21):1254-8. PubMed ID: 6803159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immune thrombocytopenic purpura].
    Cajozzo A, Abbadessa V, Perricone R, Mitra ME, Cajozzo M.
    Recenti Prog Med; 1985 Oct 27; 76(10):529-36. PubMed ID: 3911315
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.